Sign In
Buy AMRS
$0.0500
+0 (+0%)
At Close: Nov 27, 2023
Amyris, Inc. Reports Second Quarter 2020 Results
12:30pm, Thursday, 06'th Aug 2020
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today a
Brokerages Expect Amyris Inc (NASDAQ:AMRS) Will Announce Earnings of -$0.19 Per Share
07:30am, Tuesday, 04'th Aug 2020
Equities research analysts expect that Amyris Inc (NASDAQ:AMRS) will report ($0.19) earnings per share (EPS) for the current quarter, Zacks reports. Two analysts have issued estimates for Amyris’ ea
Top Marijuana Stocks for August 2020
07:21pm, Thursday, 30'th Jul 2020
The marijuana industry is made up of companies that either support or are engaged in the research, development, distribution, and sale of medical and recreational marijuana. Many big marijuana compan
Rigrodsky & Long, P.A. Files Class Action Suit Against Amyris, Inc.
09:01pm, Wednesday, 29'th Jul 2020
WILMINGTON, Del., July 29, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on beha
INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Amyris, Inc. - AMRS
04:25pm, Wednesday, 29'th Jul 2020
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Amyris, Inc. ("Amy
SHAREHOLDER ALERT: WeissLaw LLP Investigates Amyris, Inc.
01:07am, Wednesday, 29'th Jul 2020
URGENT: SHAREHOLDER VOTE AUGUST 14, 2020
Here's Why Amyris Stock Rose as Much as 12.2% Today | The Motley Fool
04:41pm, Monday, 27'th Jul 2020
The synthetic biology pioneer announced a collaboration for its vaccine adjuvant ambitions.
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets and IDRI (Infectious Disease Research Institute) today announce the signing of a binding term
Amyris To Host Second Quarter 2020 Financial Results Conference Call On August 6
12:30pm, Thursday, 23'rd Jul 2020
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today a
9 Lesser-Known Marijuana Stocks to Consider Post-Pandemic
06:01pm, Wednesday, 22'nd Jul 2020
Strangely enough, the awful coronavirus pandemic that hurt smaller marijuana stocks could be the catalyst for a sizable recovery.
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc.
LOS ANGELES, CA / ACCESSWIRE / July 20, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Amyris, Inc.
WILMINGTON, DE / ACCESSWIRE / July 20, 2020 / Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims agains
LOS ANGELES, CA / ACCESSWIRE / July 16, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Amyris, Inc. ("A
